Advisors Preferred, LLC United Therapeutics Corp Transaction History

Advisors Preferred, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$211.82 - $248.24 $4.19 Million - $4.91 Million	19,780 New	19,780 $4.47 Million
Q4 2020 Feb 03, 2021	SELL	$101.87 - $151.79 $459,637 - $684,876	-4,512 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $76,923 - $93,270	-770 Reduced 14.58%	4,512 $456,000
Q2 2020 Aug 11, 2020	BUY	$92.74 - $125.82 $489,852 - $664,581	5,282 New	5,282 $639,000
Q1 2020 Apr 20, 2020	SELL	$79.39 - $115.35 $226,976 - $329,785	-2,859 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$78.31 - $95.34 $223,888 - $272,577	2,859 New	2,859 $252,000

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.